IOVA icon

Iovance Biotherapeutics
IOVA

Overview Fund Activity

272 hedge funds and large institutions have $3.22B invested in Iovance Biotherapeutics in 2024 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 90 increasing their positions, 82 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
272
Holders Change
+37
Holders Change %
+15.74%
% of All Funds
3.94%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.12%
New
70
Increased
90
Reduced
82
Closed
33
Calls
$93.8M
Puts
$31.4M
Net Calls
+$62.4M
Net Calls Change
+$27.6M

Top Buyers

1
PA
Perceptive Advisors
New York
$286M
2
ACA
Avoro Capital Advisors
New York
$173M
3
MFM
MHR Fund Management
New York
$356M
4
SPPAM
Summit Partners Public Asset Management
Massachusetts
$44M
5
SCM
Soleus Capital Management
Connecticut
$51.9M

Top Sellers

1
State Street
State Street
Massachusetts
$154M
2
Morgan Stanley
Morgan Stanley
New York
$39.9M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
$17.8M
4
O
OrbiMed
New York
$0
5
Pictet Asset Management
Pictet Asset Management
Switzerland
$47.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
US Bancorp
151
US Bancorp
Minnesota
$468K +$249K +16,800 +114%
Envestnet Asset Management
152
Envestnet Asset Management
Illinois
$465K +$103K +6,957 +28%
Wolverine Trading
153
Wolverine Trading
Illinois
$451K -$1.36M -91,676 -75%
GC
154
Grimes & Company
Massachusetts
$433K -$85.2K -5,748 -16%
KAS
155
Kestra Advisory Services
Texas
$431K +$431K +29,083 New
GS
156
GTS Securities
New York
$430K -$558K -37,649 -56%
Victory Capital Management
157
Victory Capital Management
Texas
$429K +$30.2K +2,036 +8%
EFM
158
E Fund Management
China
$409K -$580K -39,136 -59%
CIC
159
Carnegie Investment Counsel
Ohio
$406K – – –
Cambridge Investment Research Advisors
160
Cambridge Investment Research Advisors
Iowa
$404K +$404K +27,260 New
FCM
161
Farallon Capital Management
California
$385K -$7.94M -536,000 -95%
TRCT
162
Tower Research Capital (TRC)
New York
$385K +$185K +12,470 +93%
GT
163
Glenmede Trust
Pennsylvania
$374K +$374K +25,233 New
SC
164
Saturna Capital
Washington
$373K – – –
HSBC Holdings
165
HSBC Holdings
United Kingdom
$365K +$365K +24,644 New
CM
166
Caption Management
Oklahoma
$352K +$352K +23,722 New
CFM
167
Catalyst Funds Management
Australia
$347K +$347K +23,400 New
AIP
168
Ameritas Investment Partners
Nebraska
$341K – – –
P8IP
169
Pier 88 Investment Partners
California
$339K -$65.1K -4,390 -16%
NRD
170
Nebula Research & Development
New York
$332K +$332K +22,412 New
ACM
171
Aquatic Capital Management
Illinois
$325K +$325K +21,900 New
FBC
172
Fairfield, Bush & Co
Connecticut
$318K +$316K +21,330 +17,775%
Wealth Enhancement Advisory Services
173
Wealth Enhancement Advisory Services
Minnesota
$310K +$44.3K +2,987 +17%
Allianz Asset Management
174
Allianz Asset Management
Germany
$308K +$308K +20,800 New
TC
175
TwinBeech Capital
New York
$298K +$298K +20,077 New
5 6
7
8 9